IMPACT OF IMMUNE-CHECKPOINT INHIBITORS ON LONG-TERM DISEASE COURSE OF AND DEVELOPMENT OF MICROSCOPIC COLITIS

被引：0
|
作者：
Fredrick, Thomas W.
Ramos, Guilherme P.
Braga Neto, Manuel B.
Kane, Sunanda V.
Faubion, William
Loftus, Edward V.
Pardi, Darrell S.
Raffals, Laura H.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
242
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Clinical Course and Impact of Immune-Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
    Fredrick, Thomas W.
    Ramos, Guilherme P.
    Braga Neto, Manuel B.
    Kane, Sunanda
    Faubion, William A.
    Loftus, Edward, V
    Pardi, Darrell S.
    Pasha, Shabana F.
    Farraye, Francis A.
    Zhang, Lizhi
    Raffals, Laura E.
    CROHNS & COLITIS 360, 2022, 4 (02)
  • [2] Immune-checkpoint inhibitors: long-term implications of toxicity
    Johnson, Douglas B.
    Nebhan, Caroline A.
    Moslehi, Javid J.
    Balko, Justin M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 254 - 267
  • [3] Immune-checkpoint inhibitors: long-term implications of toxicity
    Douglas B. Johnson
    Caroline A. Nebhan
    Javid J. Moslehi
    Justin M. Balko
    Nature Reviews Clinical Oncology, 2022, 19 : 254 - 267
  • [4] Immune Checkpoint Inhibitors in Patients With Microscopic Colitis
    Farha, Natalie
    Sleiman, Joseph
    Philpott, Jessica
    Funchain, Pauline
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S787 - S787
  • [5] LONG-TERM CLINICAL COURSE OF MICROSCOPIC AND COLLAGENOUS COLITIS
    CHEONG, DMO
    RUDERMAN, WB
    BONNER, GF
    WEXNER, SD
    LUCAS, FV
    GASTROENTEROLOGY, 1993, 104 (04) : A1034 - A1034
  • [6] Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
    de Moel, Emma C.
    Rozeman, Elisa A.
    Kapiteijn, Ellen H.
    Verdegaal, Els M. E.
    Grummels, Annette
    Bakker, Jaap A.
    Huizinga, Tom W. J.
    Haanen, John B.
    Toes, Rene E. M.
    van der Woude, Diane
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) : 6 - 11
  • [7] Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors
    de Andrea, Carlos Eduardo
    Perez-Gracia, Jose Luis
    Castanon, Eduardo
    Ponz-Sarvise, Mariano
    Echeveste, Jose I.
    Melero, Ignacio
    Sanmamed, Miguel F.
    Rodriguez-Ruiz, Maria Esperanza
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [8] Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
    Hughes, Michael S.
    Molina, Gabriel E.
    Chen, Steven T.
    Zheng, Hui
    Deshpande, Vikram
    Fadden, Riley
    Sullivan, Ryan J.
    Dougan, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [9] SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
    Grover, Shilpa
    Ruan, Alex
    Srivoleti, Padma
    Giobbie-Hurder, Anita
    Braschi-Amirfarzan, Marta
    Srivastava, Amitabh
    Buchbinder, Elizabeth
    Ott, Patrick
    Hodi, F. Stephen
    Kehl, Kenneth
    Awad, Mark
    Rahma, Osama
    GASTROENTEROLOGY, 2020, 158 (06) : S537 - S537
  • [10] Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management
    Abu-Sbeih, Hamzah
    Ali, Faisal S.
    Wang, Yinghong
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (01) : 25 - 32
12345